Gilles Salles

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.780Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-0803

Top 26%

0.780DataRank

Top 26%18 citations

Nicola J. Camp, Sonja I. Berndt, Brenda M. Birmann, Alexandra Nieters, Paige M. Bracci +28 more

Papers

Driven by 61 papers — median percentile 74. Top paper: “Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring”.

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2183

N/A

0.850DataRank · unranked

22 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-0803

Top 26%

0.780DataRank

Top 26%18 citations

Nicola J. Camp, Sonja I. Berndt, Brenda M. Birmann, Alexandra Nieters, Paige M. Bracci +28 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1845339

N/A

0.200DataRank · unranked

2 citations

Peter Hillmen, Gilles Salles, Jeff P. Sharman, Stephan Stilgenbauer, Oksana Gurtovaya +6 more

Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

WOS(2020)10.17615/8581-7w55

N/A

0DataRank · unranked

0 citations

Sonja I. Berndt, Meredith Yeager, Gilles Salles, Anne Kricker, Lindsay M. Morton +27 more

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

Blood Cancer Journal(2021)10.1038/s41408-021-00521-4

N/A

0DataRank · unranked

66 citations

Angelo Famà, Melissa C. Larson, Andrew L. Feldman, José C. Villasboas, Zhi-Zhang Yang +20 more

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Blood Advances(2021)10.1182/bloodadvances.2021004939

N/A

0DataRank · unranked

42 citations

Karen Chau, Jasme Lee, Jisun Lee, Dana L. Casey, Joanna C. Yang +13 more

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma

American Journal of Hematology(2021)10.1002/ajh.26149

N/A

0DataRank · unranked

22 citations

Lasse Hjort Jakobsen, Raphael Mwangi, Norbert Schmitz, Umar Farooq, C. R. Flowers +18 more

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

Journal of Translational Genetics and Genomics(2021)10.20517/jtgg.2021.08

N/A

0DataRank · unranked

0 citations

Mitchell J. Machiela, Moara Machado, Sophia Wang, Eleanor Kane, Susan L. Slager +77 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

0DataRank · unranked

1528 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities

Blood(2022)10.1182/blood.2021011994

N/A

0DataRank · unranked

196 citations

Santosha A. Vardhana, Gilles Salles, Lorenzo Falchi

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Leukemia(2022)10.1038/s41375-022-01711-0

N/A

0DataRank · unranked

33 citations

Vijai Joseph, Yolanda Benavente, Nicola J. Camp, Alexandra Nieters, Zhaoming Wang +95 more

Prospects in the management of patients with follicular lymphoma beyond first-line therapy

Haematologica(2022)10.3324/haematol.2021.278717

N/A

0DataRank · unranked

28 citations

Gilles Salles, David Qualls

Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm

Haematologica(2022)10.3324/haematol.2022.281724

N/A

0DataRank · unranked

16 citations

Andriy Derkach, Natasha Lewis, Menglei Zhu, Yanming Zhang, Maria E. Arcila +4 more

Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.08.001

N/A

0DataRank · unranked

9 citations

Ana Alarcón Tomás, Jessica Flynn, Joshua Fein, Anna Alperovich, Theodora Anagnostou +19 more

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006555

N/A

0DataRank · unranked

6 citations

Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew J. Matasar, Colette Owens +10 more

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

British Journal of Haematology(2022)10.1111/bjh.18590

N/A

0DataRank · unranked

2 citations

Brandon S. Imber, Michelle Okwali, Paul A. Hamlin, Anita Kumar, Oscar Lahoud +11 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675

N/A

0DataRank · unranked

1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

CAR T‐cell therapy in large B cell lymphoma

Hematological Oncology(2023)10.1002/hon.3153

N/A

0DataRank · unranked

50 citations

Gilles Salles, Alexander P. Boardman

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Blood(2023)10.1182/blood.2023021274

N/A

0DataRank · unranked

47 citations

Nicholas Lambert, Paolo F. Caimi, Mwanasha H. Merrill, Priyanka Pullarkat, Richard Godby +19 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9

N/A

0DataRank · unranked

29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00203-0

N/A

0DataRank · unranked

29 citations

Doris Leithner, Jennifer Alvén, Gabriele Campanella, Murad Abusamra, Honglei Zhang +12 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010003

N/A

0DataRank · unranked

22 citations

Soo‐Jeong Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M Hanley +19 more

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2022.2164194

N/A

0DataRank · unranked

9 citations

Ariela Noy, David J. Straus, Matthew J. Matasar, Craig H. Moskowitz, Venkatraman Seshan +6 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2

Hematological Oncology(2023)10.1002/hon.3166_ot28

N/A

0DataRank · unranked

6 citations

Martine E.D. Chamuleau, Georg Lenz, Michael Roost Clausen, Corinne Haïoun, Koji Izutsu +11 more

Data from Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

(2023)10.1158/1078-0432.c.6530889.v1

N/A

0DataRank · unranked

0 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01540-x

N/A

0DataRank · unranked

39 citations

Jessica Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng +23 more

Atrial arrhythmias following CAR‐chimeric antigen receptor T‐cell therapy: Incidence, risk factors and biomarker profile

British Journal of Haematology(2024)10.1111/bjh.19497

N/A

0DataRank · unranked

16 citations

Adam Goldman, Jessica Flynn, Ahmed El‐Moghraby, Mahin Rehman, Sean M. Devlin +20 more

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.010

N/A

0DataRank · unranked

12 citations

Alejandro Luna, Gunjan L. Shah, Sean M. Devlin, Magdalena Corona, Joshua Fein +13 more

Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0163

N/A

0DataRank · unranked

12 citations

Susan DeWolf, Teng Fei, Sandeep Raj, Gunjan L. Shah, Caleb A. Lareau +18 more

Lymphoma Classifications, How to Develop a Future Unified Taxonomy

Journal of Clinical Oncology(2024)10.1200/jco.24.00070

N/A

0DataRank · unranked

14 citations

Daan Dierickx, Stefan Dirnhofer, Kieron Dunleavy, Philippe Gaulard, Robert P. Hasserjian +9 more

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Blood Advances(2024)10.1182/bloodadvances.2024014555

N/A

0DataRank · unranked

13 citations

Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna +15 more

Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?

Haematologica(2024)10.3324/haematol.2022.282362

N/A

0DataRank · unranked

9 citations

Gilles Salles, Paola Ghione

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054

N/A

0DataRank · unranked

9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma

Research Square(2024)10.21203/rs.3.rs-4619285/v1

N/A

0DataRank · unranked

2 citations

M. Lia Palomba, Karlo Perica, Sean M. Devlin, Gunjan L. Shah, Parastoo B. Dahi +28 more

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

UNC Libraries(2024)10.17615/1b8m-w521

N/A

0DataRank · unranked

0 citations

Heather J. Sutherland, Paul Brennan, Laurie Burdett, Nicola J. Camp, Xiaosheng Wu +95 more

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

UNC Libraries(2024)10.17615/e1wv-7413

N/A

0DataRank · unranked

0 citations

Sílvia de Sanjosé, Ruth C. Travis, Paul Brennan, Michael Dean, Weiyin Zhou +77 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Molecular Therapy(2025)10.1016/j.ymthe.2025.03.048

N/A

0DataRank · unranked

13 citations

Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R. Scheffer Cliff, Doris K. Hansen +6 more

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Blood Cancer Journal(2025)10.1038/s41408-025-01321-w

N/A

0DataRank · unranked

11 citations

Stephanie Lobaugh, Danny Luan, Marina Gómez-Llobell, P Subramanian, Sean M. Devlin +22 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

Bone Marrow Transplantation(2025)10.1038/s41409-025-02519-z

N/A

0DataRank · unranked

5 citations

Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Jessica Flynn +22 more

Leveraging immunologically based therapies to treat diffuse large B-cell lymphoma

Trends in cancer(2025)10.1016/j.trecan.2025.06.013

N/A

0DataRank · unranked

3 citations

Sean E. Healton, Gilles Salles, Jennifer Kimberly Lue

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Blood Advances(2025)10.1182/bloodadvances.2025018079

N/A

0DataRank · unranked

3 citations

Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand, John P. Leonard, Loretta J. Nastoupil +20 more

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01273-1

N/A

0DataRank · unranked

4 citations

Sean M. Devlin, Kai Rejeski, Jessica Flynn, Magdalena Corona, Efrat Luttwak +21 more

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants

Blood Advances(2025)10.1182/bloodadvances.2025016810

N/A

0DataRank · unranked

2 citations

Diana Mandelker, Maria E. Arcila, Venkatraman Seshan, Mary Beth Terry, Vijai Joseph +11 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more

gneSeqCOO: a novel method for classifying diffuse large B-cell lymphoma cell of origin based on bulk tumor RNA sequencing profiles

Leukemia & lymphoma/Leukemia and lymphoma(2025)10.1080/10428194.2024.2446613

N/A

0DataRank · unranked

2 citations

Yi Cao, Franck Morschhauser, Gilles Salles, Yanwen Jiang, Alessia Bottos +3 more

Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses

International Journal of Cancer(2025)10.1002/ijc.70039

N/A

0DataRank · unranked

0 citations

Eleanor Kane, Lauren R. Teras, Mitchell J. Machiela, Joshua Arias, Orestis A. Panagiotou +70 more

Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma

HemaSphere(2025)10.1002/hem3.70248

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Sean M. Devlin, Alexander P. Boardman, Giulio Cassanello, Magdalena Corona +19 more

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

Frontiers in Oncology(2020)10.3389/fonc.2019.01539

N/A

0DataRank · unranked

9 citations

Eleanor Kane, Zhaoming Wang, Orestis A. Panagiotou, Lauren R. Teras, Alain Monnereau +74 more

Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8052

N/A

0DataRank · unranked

1 citations

Angelo Famà, Melissa C. Larson, Andew L. Feldman, Zhi-Zhang Yang, José C. Villasboas +13 more

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

UNC Libraries(2020)10.17615/y5gv-3561

N/A

0DataRank · unranked

0 citations

Anneclaire J. De Roos, Brian K. Link, Anne J. Novak, Yuanqing Ye, Mitchell J. Machiela +95 more

Gilles Salles

Indexed papers

Top data-sharing exemplar

Papers